The Plateau State Government on Sunday said that Echitab Polyvalent Anti-Snake Venom (ASV) is readily available, widely distributed, and provided completely free of charge to all snakebite victims across the state.
In a statement released by Pharm. Kim Jerry Bot, Director General of the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA), the government emphasized that snakebite is treated as a medical emergency, with no life to be lost due to lack of access, cost, or delay.
The statement highlighted a well-coordinated supply chain that has stocked adequate quantities of Echitab ASV in strategic hospitals, general hospitals, and designated treatment centres.
This ensures prompt treatment for victims in both remote villages and urban areas, without any financial burden on patients or their families.
The statement further reads that key assurances include sufficient stock of Echitab ASV is currently available as well as ongoing distribution to all 17 Local Government Areas (LGAs) and treatment centres.
The statement also reads that Health workers have been instructed to administer the anti-venom immediately upon diagnosis.
The PS-DMCMA warned that any health facility, staff member, or individual found withholding, diverting, or charging for the life-saving drug will face decisive action.
“The lives of Plateau citizens are priceless,” the statement declared.
The initiative was praised as a testament to the compassionate, people-centred leadership of Governor Caleb Mutfwang. By making Echitab ASV free, the Governor has reinforced that “healthcare in Plateau State is not a privilege — it is a right.”
Plateau State is positioning itself as a model for the nation, demonstrating that “leadership with conscience delivers real results.”
Hospitals and health facilities yet to receive their stock are urged to collect supplies from the PS-DMCMA Pharmagrade Warehouse, ensuring they bring appropriate cold chain equipment for proper storage.
The distribution plan, approved by the Honourable Commissioner for Health, Dr. Nicholas Baamlong, has been detailed and shared with relevant stakeholders,the statement further reads.
